IMCgp100 (tebentafusp)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IMCgp100 (tebentafusp), covering 2024-07-24 to 2024-07-24. Get the full timeline:
Most recent: Clinical Trial Update: Phase 1b/2 Study of the Combination of IMCgp100 With Durvalumab and/or Tremelimumab in Advanced Cutaneous Melanoma [Phase 1, Phase 2]